Design
Editorial
Authors
Loading...
Urges scrutiny of legacy cardiovascular drugs; leaves open systematic reassessment of pre-1962 approvals in contemporary guidelines.
Key points are not available for this paper at this time.
Edward D. Freis (1970) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: